LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
52.61
+0.83 (1.60%)
Oct 14, 2025, 3:39 PM EDT - Market open
LivaNova Revenue
LivaNova had revenue of $352.52M in the quarter ending June 30, 2025, with 10.66% growth. This brings the company's revenue in the last twelve months to $1.31B, up 8.23% year-over-year. In the year 2024, LivaNova had annual revenue of $1.25B with 8.66% growth.
Revenue (ttm)
$1.31B
Revenue Growth
+8.23%
P/S Ratio
2.15
Revenue / Employee
$451,493
Employees
2,900
Market Cap
2.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.25B | 99.89M | 8.66% |
| Dec 31, 2023 | 1.15B | 131.74M | 12.89% |
| Dec 31, 2022 | 1.02B | -13.56M | -1.31% |
| Dec 31, 2021 | 1.04B | 101.12M | 10.82% |
| Dec 31, 2020 | 934.24M | -149.93M | -13.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
LIVN News
- 6 days ago - LivaNova to Announce Third-Quarter 2025 Results - Business Wire
- 7 days ago - LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting - Business Wire
- 4 weeks ago - LivaNova PLC (LIVN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - LivaNova Appoints Donald Zurbay as a New Director - Business Wire
- 7 weeks ago - LivaNova to Host Investor Day on November 12, 2025 - Business Wire
- 7 weeks ago - LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September - Business Wire
- 2 months ago - LivaNova Launches Essenz Perfusion System in China - Business Wire
- 2 months ago - LivaNova PLC (LIVN) Q2 2025 Earnings Call Transcript - Seeking Alpha